HEM Pharma Inc. (KOSDAQ:376270)
South Korea · Delayed Price · Currency is KRW 39,900
-300 (-0.75%)
At close: Jul 24, 2026
HEM Pharma Market Cap
HEM Pharma has a market cap or net worth of 286.33 billion as of July 24, 2026. Its market cap has increased by 112.86% in one year.
Market Cap
286.33B
Enterprise Value
293.58B
Revenue
14.41B
Ranking
n/a
PE Ratio
n/a
Stock Price
39,900.00
ChartMarket Cap Chart
Since November 5, 2024, HEM Pharma's market cap has increased from 114.18B to 286.33B, an increase of 150.78%. That is a compound annual growth rate of 70.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 286.33B | -12.57% |
| Dec 30, 2025 | 327.49B | 185.09% |
| Dec 30, 2024 | 114.87B | 0.61% |
| Nov 5, 2024 | 114.18B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| G2GBIO | 465.75B |
| ImmuneOncia Therapeutics | 251.91B |
| NOVAREX | 219.84B |
| Cosmax Nbt | 160.33B |
| CellBion | 159.12B |
| DAE HWA Pharmaceutical | 157.30B |
| Vivozon Pharmaceutical | 141.69B |
| GC WellBeing | 139.52B |